Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

PTN

Palatin Technologies (PTN)

Palatin Technologies Inc New
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:PTN
DateTimeSourceHeadlineSymbolCompany
12/15/20234:03PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:PTNPalatin Technologies Inc New
12/08/20235:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PTNPalatin Technologies Inc New
12/06/20235:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PTNPalatin Technologies Inc New
12/06/20232:25PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesAMEX:PTNPalatin Technologies Inc New
12/04/20235:00PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:PTNPalatin Technologies Inc New
12/01/20233:52PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesAMEX:PTNPalatin Technologies Inc New
11/14/20237:30AMPR Newswire (US)Palatin Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate UpdateAMEX:PTNPalatin Technologies Inc New
11/09/20237:30AMPR Newswire (US)Palatin to Report First Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on November 14, 2023AMEX:PTNPalatin Technologies Inc New
10/24/20234:50PMPR Newswire (US)Palatin Announces Closing of $5 Million Registered Direct OfferingAMEX:PTNPalatin Technologies Inc New
10/24/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:PTNPalatin Technologies Inc New
10/24/20232:38PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:PTNPalatin Technologies Inc New
10/23/20237:30AMPR Newswire (US)Palatin Announces $5 Million Registered Direct OfferingAMEX:PTNPalatin Technologies Inc New
10/19/20238:01AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:PTNPalatin Technologies Inc New
10/19/20237:30AMPR Newswire (US)Palatin Announces Preliminary Quarter Ended September 30, 2023 Vyleesi® Product Revenue ResultsAMEX:PTNPalatin Technologies Inc New
10/18/20237:30AMPR Newswire (US)Palatin Announces Positive Preclinical Data Showing Synergistic Weight Loss; Initiating Clinical Study of Melanocortin 4 Receptor Agonist + GLP-1 in Obese PatientsAMEX:PTNPalatin Technologies Inc New
10/16/20237:30AMPR Newswire (US)Palatin Presents Data at the United European Gastroenterology Week 2023 Conference On PL8177 Ulcerative Colitis TreatmentAMEX:PTNPalatin Technologies Inc New
10/13/20234:31PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:PTNPalatin Technologies Inc New
10/13/20234:15PMPR Newswire (US)Palatin Receives Notice of Non-Compliance from NYSE AmericanAMEX:PTNPalatin Technologies Inc New
09/28/20238:02AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:PTNPalatin Technologies Inc New
09/28/20238:00AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]AMEX:PTNPalatin Technologies Inc New
09/28/20237:30AMPR Newswire (US)Palatin Reports Fourth Quarter and Fiscal Year Ended 2023 Financial Results and Provides Corporate UpdateAMEX:PTNPalatin Technologies Inc New
09/22/20234:00PMPR Newswire (US)Palatin to Report Fourth Quarter and Fiscal Year End 2023 Results; Teleconference and Webcast to be held on September 28, 2023AMEX:PTNPalatin Technologies Inc New
09/08/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:PTNPalatin Technologies Inc New
09/07/20234:00PMPR Newswire (US)Palatin to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceAMEX:PTNPalatin Technologies Inc New
09/07/20238:49AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:PTNPalatin Technologies Inc New
09/07/20237:30AMPR Newswire (US)Palatin Completes Enrollment in Phase 3 MELODY-1 Study of PL9643 For the Treatment of Patients with Dry Eye DiseaseAMEX:PTNPalatin Technologies Inc New
08/16/20239:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PTNPalatin Technologies Inc New
08/16/20239:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PTNPalatin Technologies Inc New
08/10/20238:15AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:PTNPalatin Technologies Inc New
08/10/20237:30AMPR Newswire (US)Palatin Initiates Clinical Program for Bremelanotide Co-Formulated with a PDE5i for the Treatment of ED in Patients Non-Responsive to PDE5i TreatmentAMEX:PTNPalatin Technologies Inc New
 Showing the most relevant articles for your search:AMEX:PTN